• (602) 222-2221
  • Request an Appointment
  • Refer A Patient
Retinal Consultants of Arizona
  • Refer a Patient
  • Request an Appointment
  • (602) 222-2221
  • Patients
    • Locations
    • Info on Covid-19
    • RCA Doctors
    • Accepted Insurance Plans
    • Your Visit
    • Patient Portal
    • Online Bill Pay
    • FAQs
    • About RCA
    • Accessibility Office
  • Referring Providers
    • Refer A Patient
    • RCA Doctors
    • Current Studies & Trials
    • About RCA
  • Conditions We Treat
    • Diabetic Macular Edema
    • Diabetic Retinopathy
    • Flashes
    • Floaters
    • Low Vision (Referral Only)
    • Macular Degeneration
    • Macular Hole
    • Macular Pucker (Epiretinal Membrane)
    • Posterior Vitreous Separation
    • Retinal Artery Occlusions
    • Retinal Detachment
    • Retinal Tear
    • Retinal Vein Occlusions
    • Uveitis
    • All Conditions
  • Research
    • About the Institute
    • Clinical Trials
    • FDA Approval Process
    • Clinical Research Trial Terms
    • Current Studies & Trials
  • Our Doctors
  • Locations
    • Phoenix Metro
      • Gilbert
      • Mesa
      • Peoria
      • Phoenix – Biltmore
      • Phoenix – North
      • Goodyear – Litchfield Rd.
      • Scottsdale – McCormick
      • Scottsdale – Hayden & Shea
      • Sun Lakes
    • Northern Arizona
      • Bullhead City
      • Cottonwood
      • Flagstaff
      • Kingman
      • Lake Havasu City
      • Payson
      • Prescott
    • Southern Arizona
      • Yuma – 28th St.
      • Yuma Foothills
  • Menu Menu

Retinal Research Institute – Phoenix

Retinal Consultants of Arizona has a strong commitment to medical research and the advancement of treatments for retinal diseases. Unfortunately, there are many medical conditions that do not have a “cure.” Although we provide the latest technology available to treat retinal disorders, we are actively involved in multiple clinical research trials in hopes of expanding our treatment options for our patients. RCA physicians contribute to the advancement of new therapies by participating in clinical research studies.

We have been participating in clinical trials since 1998 and are proud that the Retinal Research Institute has become one of the nation’s largest retina & vitreous-specific research organizations. In many instances, RCA is the only retina group in Arizona to offer patient participation in multiple studies addressing multiple eye conditions

Mission / Purpose

Retinal Consultants of Arizona’s mission is to provide the most up to date and effective treatments for patients with retinal diseases.

News

Keep up with new research and findings from recent studies and trials.

Pravin U. Dugel, MD: Conversations in Age-Related Macular Degeneration

November 1, 2019/ Uncategorized /by retinalconsultants

Neovascular AMD Pravin U. Dugel, MD What up-and-coming therapies for wet AMD are you most excited about and why? The therapies currently being investigated for neovascular age-related macular degeneration (nvAMD) can be stratified into 3 silos: better short-term efficacy, better long-term efficacy, and increased durability. The majority of drugs in the pipeline have focused on […]

Read more
https://www.retinalconsultantsaz.com/wp-content/uploads/2021/02/RCA-logo-transparent-1.png 0 0 retinalconsultants https://www.retinalconsultantsaz.com/wp-content/uploads/2021/02/RCA-logo-transparent-1.png retinalconsultants2019-11-01 17:37:582019-11-01 17:37:58Pravin U. Dugel, MD: Conversations in Age-Related Macular Degeneration

Pravin U. Dugel, MD: Opthea First-in-Human Clinical Data for OPT-302 in wet AMD Published in Leading Ophthalmic Journal

October 31, 2019/ Uncategorized /by retinalconsultants

Melbourne, Australia; 29 October 2019 – Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases, today announced the publication of positive data from the first-in-human clinical trial of OPT-302, in patients with neovascular (wet) age-related macular degeneration (wet AMD). The successful trial results were published today in Ophthalmology Retina, […]

Read more
https://www.retinalconsultantsaz.com/wp-content/uploads/2021/02/RCA-logo-transparent-1.png 0 0 retinalconsultants https://www.retinalconsultantsaz.com/wp-content/uploads/2021/02/RCA-logo-transparent-1.png retinalconsultants2019-10-31 14:39:092019-10-31 14:39:09Pravin U. Dugel, MD: Opthea First-in-Human Clinical Data for OPT-302 in wet AMD Published in Leading Ophthalmic Journal
Page 4 of 66«‹23456›»

Current Studies & Trials

Find out what current studies and trials we are enrolling for.

Learn More

Interested in a Clinical Trial?

If you or someone you know is interested in more information about our clinical research trials, please contact us.

(602) 222-2221

Clinical Trials About RCA

About Us

About RCA >

Blog >

Careers >

Quick Links

Refer a Patient >

Request Appointment >

Pay My Bill >

Follow Us On Social

© Copyright 2022 Retinal Consultants of Arizona | Privacy Policy | No Surprises Act (HR133) Notice | Accessibility Office
Scroll to top